The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/24611
StudyName: Eligibility Metastatic Breast Cancer NCT00509769
Date of export from the portal: 02.07.2020
Date of Upload / last change: 08.08.2017
License: Creative Commons BY 4.0

----

Description: 
A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00509769
